Chunguang Xie
Research Interests
Chunguang Xie has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Hongyan Wang
Department of Thoracic Surgery, the Fourth Hospital of Hebei Medical University, Shijiazhuang City, China
2 shared publications - Sihan Peng
Hospital of Chengdu University of Traditional Chinese Medicine, China
2 shared publications - Xiangeng Zhang
Sichuan Nursing Vocational College, Chengdu, China
2 shared publications - Xiyu Zhang
Hospital of Chengdu University of Traditional Chinese Medicine, TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Chengdu, China
2 shared publications - Ya Liu
Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publications - Ziyan Xie
Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Diabetes Research Center of Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Peking Union Medical College Chinese Academy of Medical Sciences Beijing China
2 shared publications
Latest Publications
- Open Access
- 22 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (3) , e23918
Tuina for diabetes with obesity
Background: Obesity is an independent risk factor for the occurrence and development of diabetes. Patients with diabetes combined with obesity will face serious burdens such as increase in insulin resistance and difficulty in blood glucose control. As a safe, effective, economical, and simple intervention, Tuina is more acceptable to the public than drugs. The objective of this systematic evaluation and meta-analysis is to evaluate the efficacy and safety of Tuina for diabetes with obesity. Methods: We will search the following electronic databases: PubMed, Embase, Cochrane Library, Web of science, Chinese National Knowledge Infrastructure (CNKI), Sino Med, Wanfang, Chinese Clinical Trial Registry System, China Biomedical Literature Database (CBM). The time limit for retrieving studies is from establishment to November 2020 for each database. Randomized controlled clinical trials related to Tuina intervention on diabetes with obesity will be included. Data synthesis, sensitivity analysis, subgroup analysis as well as the assessment of bias risk will be conducted by using Stata V.13.0 and Review manager 5.3 software. Results: This study will provide a quantitative and standardized evaluation for the efficacy of Tuina therapy on diabetes with obesity. Conclusion: This systematic review and meta-analysis will provide the high-quality evidence of whether Tuina is an effective intervention for diabetes with obesity. Registration number: INPLASY2020110106.
- 22 January 2021
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (3) , e23918
Open AccessTuina for diabetes with obesity
Background: Obesity is an independent risk factor for the occurrence and development of diabetes. Patients with diabetes combined with obesity will face serious burdens such as increase in insulin resistance and difficulty in blood glucose control. As a safe, effective, economical, and simple intervention, Tuina is more acceptable to the public than drugs. The objective of this systematic evaluation and meta-analysis is to evaluate the efficacy and safety of Tuina for diabetes with obesity. Methods: We will search the following electronic databases: PubMed, Embase, Cochrane Library, Web of science, Chinese National Knowledge Infrastructure (CNKI), Sino Med, Wanfang, Chinese Clinical Trial Registry System, China Biomedical Literature Database (CBM). The time limit for retrieving studies is from establishment to November 2020 for each database. Randomized controlled clinical trials related to Tuina intervention on diabetes with obesity will be included. Data synthesis, sensitivity analysis, subgroup analysis as well as the assessment of bias risk will be conducted by using Stata V.13.0 and Review manager 5.3 software. Results: This study will provide a quantitative and standardized evaluation for the efficacy of Tuina therapy on diabetes with obesity. Conclusion: This systematic review and meta-analysis will provide the high-quality evidence of whether Tuina is an effective intervention for diabetes with obesity. Registration number: INPLASY2020110106.
- Open Access
- 24 November 2020
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Tuina for diabetes with obesity: Protocol for a systematic review and meta-analysis
INPLASY2020110106 Tuina for diabetes with obesity: Protocol for a systematic review and meta-analysis Keywords: Tuina; meta-analysis; protocol; diabetes with obesity; systematic review. Download PDF – 2020110106
- 24 November 2020
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Open AccessTuina for diabetes with obesity: Protocol for a systematic review and meta-analysis
INPLASY2020110106 Tuina for diabetes with obesity: Protocol for a systematic review and meta-analysis Keywords: Tuina; meta-analysis; protocol; diabetes with obesity; systematic review. Download PDF – 2020110106
- Open Access
Effect of music intervention on mental health in patients with diabetes mellitus: protocol for a systematic review and meta-analysis of randomizsed controlled trials
Introduction: About 463 million adults aged 20–79 have diabetes globally. Mental disorders often exist in patients with diabetes as comorbidities, which can lead to aggravation of the diseases, increased difficulties in treatment, as well as elevated mortality rates. Music intervention has been applied in the treatment of comorbidities for 12 years now, but there are still no recommendations due to the lack of evidence. Thus, a meta-analysis is necessary to evaluate the effect of music intervention in treating mental disorders of patients with diabetes. Methods and analysis: We will search the following nine online electronic databases from their inception until March 2020: PubMed, Web of Science, Embase, EBSCO, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang Database, Chinese Scientific Journal Database (VIP) and Chinese Biomedical and Medical Database. We also plan to search other relevant resources, including grey literature and the reference lists of relevant publications. Only randomised controlled trials of music intervention to treat depression or anxiety in patients with diabetes will be involved. The primary outcomes include the depression score and anxiety score measured on certain scales, and the secondary outcome is safety. Data extraction will be independently implemented by two researchers. The risk of bias will be evaluated through the Cochrane Collaboration’s Risk of Bias tool. Eventually, all the data will be analysed via the Review Manager V.5.3 software. Ethics and dissemination: This meta-analysis will provide information about applying music intervention to treat depression or anxiety in patients with diabetes. No ethical approval is required because this meta-analysis is based on published data. The results of this systematic review will be published in a peer-reviewed journal. PROSPERO registration number CRD42019146439
Open AccessEffect of music intervention on mental health in patients with diabetes mellitus: protocol for a systematic review and meta-analysis of randomizsed controlled trials
Introduction: About 463 million adults aged 20–79 have diabetes globally. Mental disorders often exist in patients with diabetes as comorbidities, which can lead to aggravation of the diseases, increased difficulties in treatment, as well as elevated mortality rates. Music intervention has been applied in the treatment of comorbidities for 12 years now, but there are still no recommendations due to the lack of evidence. Thus, a meta-analysis is necessary to evaluate the effect of music intervention in treating mental disorders of patients with diabetes. Methods and analysis: We will search the following nine online electronic databases from their inception until March 2020: PubMed, Web of Science, Embase, EBSCO, Cochrane Library, Chinese National Knowledge Infrastructure, Wanfang Database, Chinese Scientific Journal Database (VIP) and Chinese Biomedical and Medical Database. We also plan to search other relevant resources, including grey literature and the reference lists of relevant publications. Only randomised controlled trials of music intervention to treat depression or anxiety in patients with diabetes will be involved. The primary outcomes include the depression score and anxiety score measured on certain scales, and the secondary outcome is safety. Data extraction will be independently implemented by two researchers. The risk of bias will be evaluated through the Cochrane Collaboration’s Risk of Bias tool. Eventually, all the data will be analysed via the Review Manager V.5.3 software. Ethics and dissemination: This meta-analysis will provide information about applying music intervention to treat depression or anxiety in patients with diabetes. No ethical approval is required because this meta-analysis is based on published data. The results of this systematic review will be published in a peer-reviewed journal. PROSPERO registration number CRD42019146439